Have to remember that pluvicto has shown a 21% complete response rate. Although that's after all of the doses.
In efficacy, Pluvicto demonstrated an rPFS of 12.02 months (versus 5.59 months), with an encouraging objective response rate (ORR) at 50.7% (versus 14.9%). Its complete response rate (21.2% versus 2.7%) was almost tenfold that in the comparator arm.
CU6 Price at posting:
$3.30 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)